Skip to search formSkip to main contentSkip to account menu

PHENTERMINE RESIN

Known as: PHENTERMINE RESIN COMPLEX 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2001
Review
2001
  • G. Glazer
  • Archives of internal medicine
  • 2001
  • Corpus ID: 960117
To clarify the efficacy of antiobesity drugs, this article reviews all long-term (> or =36 weeks), placebo-controlled trials of… 
1999
1999
OBJECTIVE The purpose of this study was to compare the impact of drug therapy on weight loss, Beck Depression Inventory (BDI… 
1997
1997
  • T. Coyne
  • Archives of internal medicine
  • 1997
  • Corpus ID: 21328007
In a commentary on the treatment of obesity by Kushner,1reference is made to the landmark 1992 study of Weintraub,2which was a… 
1997
1997
OBJECTIVE To determine the safety, efficacy, and metabolic changes in patients with morbid obesity treated with d,l-fenfluramine… 
1997
1997
Coyne is correct in pointing out that the Weintraub 1 trial used phentermine resin rather than phentermine hydrochloride. This… 
Highly Cited
1992
Highly Cited
1992
To investigate the value of anorexiant medications as an adjunct to other forms of weight control therapy, we studied 121 people… 
1992
1992
To assess continued efficacy of anorexiants after 3 years of use, 52 participants (43% of those starting) entered a second double… 
Highly Cited
1984
Highly Cited
1984
We performed a double-blind, controlled clinical trial comparing phentermine resin (30 mg in the morning), fenfluramine… 
1978
1978
  • C. R. Roberts
  • The American journal of psychiatry
  • 1978
  • Corpus ID: 42236652
The author treated 12 patients who had demonstrated only a minimal response to psychiatric treatment alone for their obesity with…